Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Non-alcoholic Fatty Liver Disease | 4 | 2021 | 400 | 1.290 |
Why?
|
| Liver Cirrhosis | 6 | 2024 | 899 | 0.870 |
Why?
|
| Apolipoproteins B | 5 | 2010 | 140 | 0.850 |
Why?
|
| Lipoproteins, VLDL | 5 | 2018 | 53 | 0.770 |
Why?
|
| Fatty Liver | 3 | 2024 | 214 | 0.690 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 152 | 0.590 |
Why?
|
| Lipase | 1 | 2018 | 88 | 0.550 |
Why?
|
| Lipoproteins | 1 | 2019 | 183 | 0.540 |
Why?
|
| Models, Molecular | 5 | 2010 | 1084 | 0.460 |
Why?
|
| Colectomy | 1 | 2015 | 94 | 0.440 |
Why?
|
| Liver Diseases | 1 | 2019 | 383 | 0.440 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 80 | 0.410 |
Why?
|
| Alanine Transaminase | 1 | 2014 | 158 | 0.400 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 216 | 0.390 |
Why?
|
| Nutrition Surveys | 3 | 2024 | 306 | 0.370 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 393 | 0.370 |
Why?
|
| Patient Readmission | 1 | 2015 | 417 | 0.360 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1611 | 0.320 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 611 | 0.320 |
Why?
|
| Antigens, CD | 4 | 2024 | 418 | 0.310 |
Why?
|
| Apyrase | 3 | 2019 | 21 | 0.310 |
Why?
|
| Blood Proteins | 2 | 2009 | 137 | 0.300 |
Why?
|
| Egg Proteins, Dietary | 2 | 2006 | 2 | 0.290 |
Why?
|
| Microfilament Proteins | 3 | 2009 | 272 | 0.280 |
Why?
|
| Protein Structure, Tertiary | 8 | 2010 | 723 | 0.270 |
Why?
|
| Phosphoproteins | 2 | 2009 | 435 | 0.270 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2019 | 75 | 0.260 |
Why?
|
| Keratin-18 | 2 | 2016 | 9 | 0.240 |
Why?
|
| Lipoproteins, LDL | 3 | 2018 | 119 | 0.240 |
Why?
|
| Trypsin | 1 | 2005 | 81 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 623 | 0.210 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 1395 | 0.210 |
Why?
|
| Portal Vein | 1 | 2024 | 88 | 0.210 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2024 | 60 | 0.210 |
Why?
|
| Egg Proteins | 3 | 2010 | 29 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2024 | 168 | 0.190 |
Why?
|
| Pancreatitis | 1 | 2023 | 140 | 0.190 |
Why?
|
| Neutrophils | 1 | 2024 | 367 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 369 | 0.180 |
Why?
|
| Middle Aged | 10 | 2024 | 28736 | 0.170 |
Why?
|
| Proteomics | 1 | 2025 | 597 | 0.170 |
Why?
|
| Humans | 25 | 2025 | 130939 | 0.170 |
Why?
|
| Mutation, Missense | 3 | 2011 | 925 | 0.170 |
Why?
|
| United States | 5 | 2024 | 11718 | 0.160 |
Why?
|
| Computational Biology | 1 | 2025 | 870 | 0.160 |
Why?
|
| Adult | 8 | 2024 | 31541 | 0.160 |
Why?
|
| Protein Structure, Secondary | 4 | 2010 | 237 | 0.150 |
Why?
|
| Triglycerides | 3 | 2011 | 607 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 344 | 0.150 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2018 | 19 | 0.140 |
Why?
|
| Acyltransferases | 1 | 2018 | 61 | 0.140 |
Why?
|
| Adenoma | 1 | 2019 | 145 | 0.140 |
Why?
|
| Protein Folding | 3 | 2009 | 215 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 98 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 35 | 0.130 |
Why?
|
| ROC Curve | 2 | 2016 | 613 | 0.130 |
Why?
|
| Colonoscopy | 1 | 2019 | 247 | 0.130 |
Why?
|
| Male | 12 | 2024 | 64824 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 281 | 0.130 |
Why?
|
| Purines | 1 | 2017 | 115 | 0.130 |
Why?
|
| Circular Dichroism | 2 | 2007 | 79 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2018 | 6443 | 0.120 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2016 | 15 | 0.120 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2016 | 50 | 0.120 |
Why?
|
| Ileostomy | 1 | 2015 | 31 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2016 | 95 | 0.120 |
Why?
|
| Ascites | 1 | 2016 | 99 | 0.110 |
Why?
|
| Female | 11 | 2024 | 70759 | 0.110 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 171 | 0.110 |
Why?
|
| Steroids | 1 | 2015 | 172 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2015 | 350 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 694 | 0.100 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 2076 | 0.100 |
Why?
|
| Feces | 1 | 2017 | 724 | 0.100 |
Why?
|
| Liver | 2 | 2024 | 1790 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 409 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 633 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 323 | 0.100 |
Why?
|
| Length of Stay | 2 | 2016 | 1389 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2009 | 42 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2015 | 1233 | 0.090 |
Why?
|
| Animals | 7 | 2025 | 34283 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 2651 | 0.090 |
Why?
|
| Aged | 5 | 2024 | 21134 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2024 | 1565 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2011 | 46 | 0.090 |
Why?
|
| Models, Chemical | 2 | 2007 | 81 | 0.080 |
Why?
|
| Apolipoproteins C | 1 | 2010 | 11 | 0.080 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 4 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2341 | 0.080 |
Why?
|
| Obesity | 1 | 2021 | 2377 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2192 | 0.080 |
Why?
|
| Protein Binding | 3 | 2010 | 1705 | 0.080 |
Why?
|
| Time Factors | 2 | 2019 | 6275 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2849 | 0.070 |
Why?
|
| Registries | 1 | 2016 | 1591 | 0.070 |
Why?
|
| Actins | 2 | 2009 | 316 | 0.070 |
Why?
|
| Kinetics | 2 | 2010 | 1101 | 0.070 |
Why?
|
| Hypobetalipoproteinemias | 1 | 2007 | 3 | 0.070 |
Why?
|
| Apolipoprotein B-100 | 1 | 2007 | 36 | 0.070 |
Why?
|
| Gelsolin | 1 | 2007 | 13 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3067 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17485 | 0.070 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2007 | 5 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3397 | 0.060 |
Why?
|
| Chylomicrons | 1 | 2006 | 10 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 1401 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2006 | 36 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 5257 | 0.060 |
Why?
|
| Escherichia coli | 3 | 2009 | 981 | 0.060 |
Why?
|
| Motion | 1 | 2006 | 39 | 0.060 |
Why?
|
| Incidence | 2 | 2024 | 3327 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 208 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 300 | 0.060 |
Why?
|
| Biomarkers | 3 | 2023 | 3365 | 0.060 |
Why?
|
| Spodoptera | 1 | 2005 | 28 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2010 | 1021 | 0.060 |
Why?
|
| Fimbriae, Bacterial | 1 | 2004 | 40 | 0.060 |
Why?
|
| Biophysics | 1 | 2005 | 49 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 50 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2005 | 140 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3799 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4645 | 0.050 |
Why?
|
| Granulocytes | 1 | 2024 | 69 | 0.050 |
Why?
|
| Bacterial Adhesion | 1 | 2004 | 102 | 0.050 |
Why?
|
| Risk Factors | 3 | 2024 | 10901 | 0.050 |
Why?
|
| Macrophages | 2 | 2019 | 665 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3850 | 0.050 |
Why?
|
| Ketone Bodies | 1 | 2023 | 40 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 139 | 0.050 |
Why?
|
| Acetylation | 1 | 2023 | 181 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3120 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4739 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 1040 | 0.050 |
Why?
|
| Cause of Death | 1 | 2024 | 507 | 0.040 |
Why?
|
| Mice | 3 | 2025 | 18414 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 353 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2023 | 342 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1235 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 5096 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2005 | 776 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1153 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 606 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1441 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2006 | 943 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1144 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1822 | 0.030 |
Why?
|
| Pyridines | 1 | 2019 | 258 | 0.030 |
Why?
|
| Dietary Fiber | 1 | 2017 | 78 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 95 | 0.030 |
Why?
|
| Income | 1 | 2017 | 135 | 0.030 |
Why?
|
| Exosomes | 1 | 2017 | 59 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2017 | 108 | 0.030 |
Why?
|
| Adenosine | 1 | 2017 | 121 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 70 | 0.030 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2016 | 12 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2016 | 70 | 0.030 |
Why?
|
| Educational Status | 1 | 2017 | 281 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 2016 | 89 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 689 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2017 | 146 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1481 | 0.030 |
Why?
|
| Aging | 1 | 2023 | 1257 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 52 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 42 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 128 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 358 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 317 | 0.030 |
Why?
|
| Binding Sites | 2 | 2010 | 1200 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 197 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 774 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1018 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 2560 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 768 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 790 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1344 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 3610 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1614 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1302 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 10040 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1500 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 79 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 87 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2011 | 96 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 957 | 0.020 |
Why?
|
| Lipoproteins, IDL | 1 | 2010 | 6 | 0.020 |
Why?
|
| Brefeldin A | 1 | 2010 | 11 | 0.020 |
Why?
|
| Microsomes | 1 | 2010 | 37 | 0.020 |
Why?
|
| Threonine | 1 | 2010 | 62 | 0.020 |
Why?
|
| Chickens | 1 | 2010 | 285 | 0.020 |
Why?
|
| Alanine | 1 | 2010 | 162 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 830 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 54 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2009 | 49 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 286 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2460 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2950 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4681 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1925 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 249 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1311 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 2004 | 20 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 2596 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 315 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2004 | 310 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2344 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13210 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 14945 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 20814 | 0.010 |
Why?
|
| Child | 1 | 2016 | 26098 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 6144 | 0.010 |
Why?
|